Bli medlem
Bli medlem

Du är här

2020-10-05

aXichem AB: aXichem's natural analogue capsaicin, aXivite, is a key ingredient in new consumer product, for histamine intolerance, to be launched in the U.S. market

- We are excited to see aXivite entering the U.S. market and being used for the histamine intolerance application, a new area for this ingredient. The product will be sold through the health care practitioner channel, one of the most dynamic segments of the natural products industry. It is a sub-market characterized by strong growth, product innovation and also the involvement of major, multinational players. I have high expectations on our future commercial development in the U.S. market, says Lucas Altepost, VP and director of sales and marketing at aXichem.

In July this year aXichem signed an agreement with Berg Nutrition regarding distribution of aXivite in the U.S. and Canada. With the signing of the agreement Berg Nutrition placed an initial order for aXivite for product development. The new product now being lunched by DIEM Direct is a result of the collaboration with Berg Nutrition and the first order.

With a 10-year compound annual growth rate (CAGR) of 8.3 percent, the practitioner channel in the U.S. is outpacing big-box stores and specialty retail, where the CAGR ranges from 4.5 to 6.2%, according to the Nutrition Business Journal (NBJ). Practitioner sales topped US$3.7 billion in 2016, accounting for roughly 9% of all supplement sales  

 

This press release was submitted by the contact person below on 5 October 2020, at 09:20 CET.

Författare aXichem AB

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.